Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia (L2009-03)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Hospices Civils de Lyon
Information provided by (Responsible Party):
Lescuyer Laboratory
ClinicalTrials.gov Identifier:
NCT01469936
First received: October 28, 2011
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)